Milou-daniel D. Drici

Nice, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Mental health safety profile of CFTR modulators in pediatrics and adults: insights from the French pharmacovigilance database and from VigiBase.

Mental health safety profile of CFTR modulators in pediatrics and adults: insights from the French pharmacovigilance database and from VigiBase.

Journal: Annals of the American Thoracic Society

Published: March 15, 2026

A new chapter in pharmacology: Artificial intelligence's expanding role in pharmacokinetics, pharmacodynamics, and pharmacovigilance.

A new chapter in pharmacology: Artificial intelligence's expanding role in pharmacokinetics, pharmacodynamics, and pharmacovigilance.

Journal: Therapie

Published: July 15, 2025

Alice in wonderland syndrome: Down the rabbit hole of VigiBase®.

Alice in wonderland syndrome: Down the rabbit hole of VigiBase®.

Journal: Psychiatry research

Published: June 27, 2025

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Journal: Headache

Published: June 12, 2025

Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database.

Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database.

Journal: BMC pharmacology & toxicology

Published: May 11, 2025

Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapers.

Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapers.

Journal: British journal of clinical pharmacology

Published: January 19, 2025

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.

Journal: Clinical kidney journal

Published: November 16, 2024

PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database.

PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database.

Journal: Frontiers in immunology

Published: October 19, 2024

Polyintoxication with cenobamate, perampanel, and carbamazepine: A complex case report.

Polyintoxication with cenobamate, perampanel, and carbamazepine: A complex case report.

Journal: Therapie

Published: June 28, 2024

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.

Journal: Drug safety

Published: March 07, 2024

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.

Journal: Drug safety

Published: March 07, 2024

Dental Adverse Effects of Anti-CD20 Therapies.

Dental Adverse Effects of Anti-CD20 Therapies.

Journal: Neurology and therapy

Published: January 17, 2024

Showing 1-12 of 71

Last Updated: 09/26/2026